Cell line |
Hypericin concentration |
Light Source |
Wavelength (nm) |
Light dose (J/cm2) |
Results |
Reference |
Human skin carcinoma (A431) |
100 µM |
Fluorescence lamps |
530
620 |
4 |
IC50
0.10 & 0.16 µM |
[6] |
Human cervix carcinoma (ME-180) |
100 µM |
Fluorescence lamps |
530
620 |
4 |
IC50
0.10 & 0.16 µM |
[6] |
Human cervix carcinoma (HeLa) |
100 µM |
Fluorescence lamps |
530
620 |
4 |
IC50
0.10 & 0.16 µM |
[6] |
Human prostate carcinoma (DU 145) |
100 µM |
Fluorescence lamps |
530
620 |
4 |
IC50
0.10 &0.16 µM |
[6] |
Human prostate adenocarcinoma (PC-3) |
100 µM |
Fluorescence lamps |
530
620 |
4 |
IC50
0.10 & 0.16 µM |
[6] |
Human breast carcinoma (MCF-7) |
100 µM |
Fluorescence lamps |
530
620 |
4 |
IC50
0.10 & 0.16 µM |
[6] |
Human prostate carcinoma |
100 µM |
Fluorescence lamps |
530
620 |
4 |
IC50
0.10 &0.16 µM |
[6] |
Human fibrosarcoma
(Hs913T) |
100 µM |
Fluorescence lamps |
530
620 |
4 |
IC50
0.10 & 0.16 µM |
[6] |
Mouse fibroblast cells (Swiss 3T3) |
100 µM |
Fluorescence lamps |
530
620 |
4 |
IC50
0.10 & 0.16 µM |
[6] |
Mouse Mammary carcinoma cells,
(EMT6)
|
0.5 µM
1.0 µM |
Fluorescent bulbs |
|
1.5 |
Nontoxic 0.5 µM + 1.5 J/cm2;
Moderately cytotoxic
1.0 µM + 1.5 J/cm2 |
[7] |
Human lymphoma (U937) |
0.2 µM |
Argon dye laser |
599 |
2.5
4 -5
8
10
18 |
No effect (2.5 J/cm2)
Critical effects
(4-5 J/cm2)
Lethal doses
(8-10 J/cm2) |
[8] |
Murine C26 colon carcinoma cells |
1 - 4 µM s |
fibre optic Noncoherent light delivery system |
550
590 |
0.3
0.6
1.2 |
LD50
1 µM
1.60 J/cm2
55O nm |
[9] |
Human Squamous oesophageal
(Kyse-140) |
10 nM - 1 µM |
100W halogen lamp |
400 – 800 |
30 |
IC50
27nM-28nM |
[10] |
Human adenocarcinoma
Oesophageal
(OE-33) |
10 nM - 1 µM |
100W halogen lamp |
400 – 800 |
30 |
IC50
27nM -28nM |
[10] |
Human Glio0.blastoma
(U373) |
1-100 µM |
Argon laser |
488 |
1 - 20 |
30% killing
100 µM
20 J/cm2 |
[11] |
Human bladder
(T24 & RT) |
20 µg/ml
60 µg/ml |
Argon-pumped dye laser |
630 |
1 – 2
4
8 |
LC50
3.6 J/cm2
60 µg/ml |
[12] |
Osteosarcoma cell line
(U2OS) |
0.06-2 µg/ml |
300W halogen lamp |
|
2.9
4.8
9.6
14.4 |
100% killing
1 µg/ml + 9.6 J/cm2 ;
0.5 µg/ml + 14.4 J/cm2 ;
IC50
0.4 µg/ml + 9.6 J/cm2 |
[13] |
Human breast adenocarcinoma
(MCF-7)
|
0.021 µM |
11 L18 W/30 lamps |
530 - 620 |
4.4 |
80% survival after 24hrs & 60% survival after 48 hrs |
[14] |
Human Breast adenocarcinoma
(MCF-7) |
0.0084 – 0.021 µM |
Lamp |
530 – 620 |
4.4 |
Greater reduction in cell viability with 48 h |
[14] |
Human epidermoid carcinoma
(A431) |
1 µM |
Red light diode array |
610 |
1.5 |
LD50
0.31 µM |
[15] |